Shilpa Medicare’s State of art facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (AP) for undertaking ‘Contract Research & Forward Integration i.e. Own Formulation’ (Manufacturing of Oral & Injectible (Onco Products) has started functioning partially. Facility for manufacture of Formulation section will commence commercial production in stages after successful completion of trial production/stability tests etc. which is underway.
The Company had visualized Contract Research as one of the thrust area few years back. It invested in creating Research & Development Centres at two places. The investment has started yielding results. It expects that this will grow in time to come and would become an important source of income, besides inventing new/improved products for the Company.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: